Analogs of human plasminogen that are labeled with fluorescence probes at the catalytic site of the zymogen. Preparation, characterization, and interaction with streptokinase
- PMID: 8557633
- DOI: 10.1074/jbc.271.2.1072
Analogs of human plasminogen that are labeled with fluorescence probes at the catalytic site of the zymogen. Preparation, characterization, and interaction with streptokinase
Abstract
Fluorescent analogs of the proteinase zymogen, plasminogen (Pg), which are specifically inactivated and labeled at the catalytic site have been prepared and characterized as probes of the mechanisms of Pg activation. The active site induced non-proteolytically in Pg by streptokinase (SK) was inactivated stoichiometrically with the thioester peptide chloromethyl ketone. N alpha-[(acetylthio)acetyl]-(D-Phe)-Phe-Arg-CH2Cl; the thiol group generated subsequently on the incorporated inhibitor with NH2OH was quantitatively labeled with the fluorescence probe, 2-((4'-iodoacetamido)anilino)naphthalene-6-sulfonic acid; and the labeled Pg was separated from SK. Cleavage of labeled [Glu]Pg1 by urokinase-type plasminogen activator (uPA) was accompanied by a fluorescence enhancement (delta Fmax/Fo) of 2.0, and formation of 1% plasmin (Pm) activity. Comparison of labeled and native [Glu]Pg1 as uPA substrates showed that activation of labeled [Glu]Pg1 generated [Glu]Pm1 as the major product, while native [Glu]Pg1 was activated at a faster rate and produced [Lys]Pm1 because of concurrent proteolysis by plasmin. When a mixture of labeled and native Pg was activated, to include plasmin-feedback reactions, the zymogens were activated at equivalent rates. The lack of potential proteolytic activity of the Pg derivatives allowed their interactions with SK to be studied under equilibrium binding conditions. SK bound to labeled [Glu]Pg1, and [Lys]Pg1 with dissociation constants of 590 +/- 110 and 110 and 11 +/- 7 nM, and fluorescence enhancements of 3.1 +/- 0.1 and 1.6 +/- 0.1, respectively. Characterization of the interaction of SK with native [Glu]Pg1 by the use of labeled [Glu]Pg1 as a probe indicated a approximately 6-fold higher affinity of SK for the native Pg zymogen compared to the labeled Pg analog. Saturating levels of epsilon-aminocaproic acid reduced the affinity of SK for labeled [Glu]Pg1 by approximately 2-fold and lowered the fluorescence enhancement to 1.8 +/- 0.1, whereas the affinity of SK for labeled [Lys]Pg1 was reduced by approximately 98-fold with little effect on the enhancement. These results demonstrate that occupation of lysine binding sites modulates the affinity of SK for Pg and the changes in the environment of the catalytic site associated with SK-induced conformational activation. Together, these studies show that the labeled Pg derivatives behave as analogs of native Pg which report functionally significant changes in the environment of the catalytic site of the zymogen.
Similar articles
-
Streptokinase binds preferentially to the extended conformation of plasminogen through lysine binding site and catalytic domain interactions.Biochemistry. 2000 Nov 14;39(45):13974-81. doi: 10.1021/bi000594i. Biochemistry. 2000. PMID: 11076540
-
Streptokinase binds to human plasmin with high affinity, perturbs the plasmin active site, and induces expression of a substrate recognition exosite for plasminogen.J Biol Chem. 2000 May 12;275(19):14579-89. doi: 10.1074/jbc.275.19.14579. J Biol Chem. 2000. PMID: 10799544
-
Resolution of conformational activation in the kinetic mechanism of plasminogen activation by streptokinase.J Biol Chem. 2004 Aug 27;279(35):36633-41. doi: 10.1074/jbc.M405264200. Epub 2004 Jun 23. J Biol Chem. 2004. PMID: 15215240
-
Pathogen activators of plasminogen.J Thromb Haemost. 2015 Jun;13 Suppl 1(0 1):S106-14. doi: 10.1111/jth.12939. J Thromb Haemost. 2015. PMID: 26149011 Free PMC article. Review.
-
Identification of small molecules that selectively inhibit streptokinase expression without suppression of viability in Group A streptococci - Probe 1.2009 Nov 16 [updated 2011 Mar 11]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010–. 2009 Nov 16 [updated 2011 Mar 11]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010–. PMID: 21735597 Free Books & Documents. Review.
Cited by
-
Analysis of the interactions between streptokinase domains and human plasminogen.Protein Sci. 1998 Oct;7(10):2190-9. doi: 10.1002/pro.5560071017. Protein Sci. 1998. PMID: 9792107 Free PMC article.
-
Novel fluorescent prothrombin analogs as probes of staphylocoagulase-prothrombin interactions.J Biol Chem. 2006 Jan 13;281(2):1169-78. doi: 10.1074/jbc.M507955200. Epub 2005 Oct 17. J Biol Chem. 2006. PMID: 16230340 Free PMC article.
-
Design of Specific Serine Protease Inhibitors Based on a Versatile Peptide Scaffold: Conversion of a Urokinase Inhibitor to a Plasma Kallikrein Inhibitor.J Med Chem. 2015 Nov 25;58(22):8868-76. doi: 10.1021/acs.jmedchem.5b01128. Epub 2015 Nov 12. J Med Chem. 2015. PMID: 26536069 Free PMC article.
-
Rapid binding of plasminogen to streptokinase in a catalytic complex reveals a three-step mechanism.J Biol Chem. 2014 Oct 3;289(40):28006-18. doi: 10.1074/jbc.M114.589077. Epub 2014 Aug 19. J Biol Chem. 2014. PMID: 25138220 Free PMC article.
-
Evidence that the conformation of unliganded human plasminogen is maintained via an intramolecular interaction between the lysine-binding site of kringle 5 and the N-terminal peptide.Biochem J. 1998 Jul 1;333 ( Pt 1)(Pt 1):99-105. doi: 10.1042/bj3330099. Biochem J. 1998. PMID: 9639568 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous